Glenmark now India's fourth-largest pharmaceutical company, in 1977, the first to enter the drug market in dermatology drug, with independent research and development center, set up production facilities in conformity with the FDA standard, established the development in the United States and Switzerland respectively the manufacturer of injection oral preparations and biological agents, and engaged in diversified API production and business operation.